Drug prices

The real winners of Trump's tax cuts:
Pfizer: $2.8B
Johnson & Johnson: $2.5B
Merck: $1.2B
Abbott Labs: $473M

Meanwhile, Pfizer, J&J, and Merck all *raised* prescription drug prices last year. So much for trickle-down benefits…https://t.co/7I0rUBxq8H

— Robert Reich (@RBReich) April 9, 2019

I can't remember this ever happening before. Republicans in Congress are encouraging pharmaceutical companies not to cooperate with an investigation into drug prices.

Once again, they're siding with Big Pharma at the expense of the American people. https://t.co/ZE1psCT8G6

— Robert Reich (@RBReich) April 8, 2019